Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Experts Support Statin, Triptan, Sleep Aid Switches In New Paradigm

This article was originally published in The Tan Sheet

Executive Summary

The American Society of Health-System Pharmacists has opposed allowing OTC sales of statins, but would support a switch made with conditions of safe use required. A Philadelphia College of Pharmacy professor argues that patients are better served by obtaining pharmaceuticals from health care professionals than using “un-standardized” dietary supplements

Advertisement

Related Content

Antiquated Nebulizers Deliver Uneven Asthma Doses – FDA Reviewers
FDA Sketched NSURE Novel Switch Initiative In 2012
FDA Sketches NSURE Novel Switch Initiative In 2012
Sponsors Should Hang Tight On “New Paradigm” Switch – CDER’s Leonard-Segal
Support Rises For Red Yeast Extract As Alternative To Statin Therapy
FDA Panel To Influenza Home MedKit Sponsors: Get Real
GSK’s Imigran Recovery Is First Triptan Approved For Nonprescription UK Sale

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105661

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel